Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 179

Results For "gene"

2932 News Found

Capnopharm to acquire operational assets of Capnomed
News | July 10, 2022

Capnopharm to acquire operational assets of Capnomed

Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.


We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region
interviews | July 08, 2022

We have consistently expanded our business in India: Vinod Paremal, President & MD, Evonik, India Region

Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing


Evonik launches non-animal-derived collagen platform for medical device applications
News | July 08, 2022

Evonik launches non-animal-derived collagen platform for medical device applications

Fermentation-based manufacturing leverages Evonik’s biotechnology platform


Lupin’s Somerset manufacturing plant Receives EIR from US FDA
Drug Approval | July 08, 2022

Lupin’s Somerset manufacturing plant Receives EIR from US FDA

The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated


Lonza to build large-scale fill & finish facility in Switzerland
News | July 07, 2022

Lonza to build large-scale fill & finish facility in Switzerland

The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026


Wacker to expand mRNA-based actives capacity at Halle, Germany
News | July 06, 2022

Wacker to expand mRNA-based actives capacity at Halle, Germany

Company is investing more than €100 million in the expansion of the Halle site


Merck launches international platform to discuss ‘Next-Gen Labs’
News | July 06, 2022

Merck launches international platform to discuss ‘Next-Gen Labs’

Merck is organizing one of the biggest South APAC Virtual Conclave on ‘Next-Gen Labs’ on 20th July.


StimLabs announces new placental membrane-based product ‘Enverse’
News | July 06, 2022

StimLabs announces new placental membrane-based product ‘Enverse’

The introduction of Enverse is part of StimLabs' aim to simplify patient care for both physicians and the hospital systems


Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance
News | July 06, 2022

Boehringer Ingelheim, Evotec and bioMérieux forms JV Aurobac to fight antimicrobial resistance

The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.